Skip to main content
Log in

Probiotics prophylaxis in infants with primary vesicoureteral reflux

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

In this era of increasing bacterial resistance to antimicrobial therapy, probiotics have great potential and yet they are a harmless alternative approach. This study is a prospective randomized uncontrolled trial to investigate the preventive effect of probiotic prophylaxis in infants with primary vesicoureteral reflux (VUR) and frequently recurring urinary tract infection (UTI) during the first follow-up year.

Methods

One hundred and twenty-eight infants (aged 1 week to 12 months) with primary VUR were prospectively randomized into a probiotic (n = 64, Lactobacillus acidophilus, 1.0 × 108 CFU/g) or antibiotic (n = 64, trimethoprim/sulfamethoxazole, 2/10 mg/kg) group.

Results

The incidence of recurrent UTI in the probiotic group was slightly lower than in the antibiotic group without statistical significance (32.8 % [21 out of 64] vs 40.6 % [26/64]) (P = 0.348). Causative organisms of recurrent UTI, resolution rate of VUR, and development of renal scarring were not different between the probiotic and antibiotic prophylaxis groups. The incidences of antibiotic resistance of causative organisms in recurrent UTI were significantly lower in the probiotic group than in the antibiotic group.

Conclusions

Probiotics could be considered a natural alternative regimen for prophylaxis in infants with primary VUR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Elder JS, Peters CA, Arant BS Jr, Ewalt DH, Hawtrey CE, Hurwitz RS, Parrott TS, Snyder HM 3rd, Weiss RA, Woolf SH, Hasselblad V (1997) Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children. J Urol 157:1846–1851

    Article  CAS  PubMed  Google Scholar 

  2. Williams G, Lee A, Craig J (2001) Antibiotics for the prevention of urinary tract infection in children: a systematic review of randomized controlled trials. J Pediatr 138:868–874

    Article  CAS  PubMed  Google Scholar 

  3. Williams GJ, Wei L, Lee A, Craig JC (2006) Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev 3:CD001534

    PubMed  Google Scholar 

  4. Thompson RH, Chen JJ, Pugach J, Naseer S, Steinhardt GF (2001) Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux. J Urol 166:1465–1469

    Article  CAS  PubMed  Google Scholar 

  5. Hellerstein S, Nickell E (2002) Prophylactic antibiotics in children at risk for urinary tract infection. Pediatr Nephrol 17:506–510

    Article  PubMed  Google Scholar 

  6. Al-Sayyad AJ, Pike JG, Leonard MP (2005) Can prophylactic antibiotics safely be discontinued in children with vesicoureteral reflux. J Urol 174:1587–1589

    Article  PubMed  Google Scholar 

  7. Cooper CS, Chung BI, Kirsch AJ, Canning DA, Snyder HM (2000) The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux. J Urol 163:269–273

    Article  CAS  PubMed  Google Scholar 

  8. Georgaki-Angelaki H, Kostaridou S, Daikos GL, Kapoyiannis A, Veletzas Z, Michos AG, Syriopoulou VP (2005) Long-term follow-up of children with vesicoureteral reflux with and without antibiotic prophylaxis. Scand J Infect Dis 37:842–845

    Article  CAS  PubMed  Google Scholar 

  9. Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L (2006) Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 117:626–632

    Article  PubMed  Google Scholar 

  10. Roussey-Kesler G, Gadjos V, Idres N, Horen B, Ichay L, Leclair MD, Raymond F, Grellier A, Hazart I, de Parscau L, Salomon R, Champion G, Leroy V, Guigonis V, Siret D, Palcoux JB, Taque S, Lemoigne A, Nguyen JM, Guyot C (2008) Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol 179:674–679

    Article  CAS  PubMed  Google Scholar 

  11. Montini G, Rigon L, Zucchetta P, Fregonese F, Toffolo A, Gobber D, Cecchin D, Pavanello L, Molinari PP, Maschio F, Zanchetta S, Cassar W, Casadio L, Crivellaro C, Fortunati P, Corsini A, Calderan A, Comacchio S, Tommasi L, Hewitt IK, Da Dalt L, Zacchello G, Dall’Amico R, IRIS Group (2008) Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, non-inferiority trial. Pediatrics 122:1064–1071

    Article  PubMed  Google Scholar 

  12. Fedorak RN, Madsen KL (2004) Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 20:146–155

    Article  PubMed  Google Scholar 

  13. Lee JW, Shim YH, Lee SJ (2009) Lactobacillus colonization status in infants with urinary tract infection. Pediatr Nephrol 24:135–139

    Article  PubMed  Google Scholar 

  14. Bruce AW, Chadwick P, Hassan A, VanCott GF (1973) Recurrent urethritis in women. Can Med Assoc J 108:973–976

    PubMed Central  CAS  PubMed  Google Scholar 

  15. Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennel CL, Stemm WE (1998) Inverse association of H2O2-producting lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infection. J Infect Dis 178:446–450

    Article  CAS  PubMed  Google Scholar 

  16. Cadieux P, Burton J, Gardiner G, Braunstein I, Bruce AW, Kang CY, Reid G (2002) Lactobacillus strains and vaginal ecology. JAMA 287:1940–1941

    Article  PubMed  Google Scholar 

  17. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, Bruce AW (2003) Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 35:131–134

    Article  CAS  PubMed  Google Scholar 

  18. Peter C, Rushton HG (2010) Vesicoureteral reflux associated renal damage: congenital reflux nephropathy and acquired renal scarring. J Urol 184:265–273

    Article  Google Scholar 

  19. Ladhani S, Gransden W (2003) Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 88:444–445

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Cheng CH, Tsai MH, Huang YC, Su LH, Tsau YK, Lin CJ, Chiu CH, Lin TY (2008) Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Pediatrics 122:1212–1217

    Article  PubMed  Google Scholar 

  21. Drisko JA, Giles CK, Bischoff BJ (2003) Probiotics in health maintenance and disease prevention. Altern Med Rev 8:143–155

    PubMed  Google Scholar 

  22. Uehara S, Monden K, Nomoto K, Seno Y, Kariyama R, Kumon H (2006) A pilot study evaluating the safety and effectiveness of lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int J Antimicrob Agents 28:S30–S34

    Article  CAS  PubMed  Google Scholar 

  23. Abad CL, Safdar N (2009) The role of lactobacillus probiotics in the treatment or prevention of urogenital infections–a systematic review. J Chemother 21:243–252

    Article  CAS  PubMed  Google Scholar 

  24. Reid G, Jass J, Sebulsky MT, McCormick JK (2003) Potential uses of probiotics in clinical practice. Clin Microbiol Rev 16:658–672

    Article  PubMed Central  PubMed  Google Scholar 

  25. McCroarty JA (1993) Probiotic use of lactobacilli in the human female urogenital tract. FEMS Immunol Med Microbiol 6:251–264

    Article  Google Scholar 

  26. Rodriguez JM, Martinez MI, Horn N, Dodd HM (2003) Heterologous production of bacteriocins by lactic acid bacteria. Int J Food Microbiol 80:101–116

    Article  CAS  PubMed  Google Scholar 

  27. Amdekar S, Singh V, Singh DD (2011) Probiotic therapy: immunomodulating approach toward urinary tract infection. Curr Microbiol 63:484–490

    Article  CAS  PubMed  Google Scholar 

  28. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B (2001) Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 30:49–52

    Article  CAS  PubMed  Google Scholar 

  29. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82:103–108

    Article  CAS  PubMed  Google Scholar 

  30. Gerasimov SV (2004) Probiotic prophylaxis in pediatric recurrent urinary tract infection. Clin Pediatr 43:95–98

    Article  Google Scholar 

  31. Lee SJ, Shim YH, Cho SJ, Lee JW (2007) Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol 22:1315–1320

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jung Won Lee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, S.J., Lee, J.W. Probiotics prophylaxis in infants with primary vesicoureteral reflux. Pediatr Nephrol 30, 609–613 (2015). https://doi.org/10.1007/s00467-014-2988-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-014-2988-z

Keywords

Navigation